Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alternative Nostril Breathing in Bronchial Asthma
NCT06609941Recruiting
- Sponsor
- Foundation University Islamabad
- Start
- Jun 2024
- Primary completion
- Jan 2025
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Foundation University Islamabad. Primary endpoints: Dyspnea at 4 weeks, Control Pause at 4 weeks and 2 more. Started Jun 2024; status: recruiting.
Beyond the preview
Go deeper on NCT06609941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06609941.